COMP <GO>
STE vs UNH // EV/EBITDA & P/E VALUATION
STERIS plc (Ireland) (NYSE) VS. UnitedHealth Group Incorporated (NYSE) • 15-METRIC TALLY: STE 7
— UNH 7
▲ EV/EBITDA & P/E VALUATION LEADER: UNH
LAST: $232.14 (+1.47%) • MKT CAP: $22.63B
valuation
17.0x
LAST: $410.91 (+0.94%) • MKT CAP: $368.83B
valuation
16.4x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (STE VS. UNH)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | STE | UNH | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 44.20% | 88.57% | -44.37 | UNH | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 10.10% | 11.47% | -1.37 | UNH | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 17.0x | 16.4x | +0.55 | UNH | /valuation <GO> |
| Free Cash Flow Yield | 4.30% | 6.48% | -2.18 | UNH | /fcf-yield <GO> |
| Operating Margin | 18.60% | 4.82% | +13.78 | STE | /operating-margins <GO> |
| Net Profit Margin | 13.20% | 3.14% | +10.06 | STE | /net-margins <GO> |
| Revenue Growth (YoY) | 8.70% | 6.46% | +2.24 | STE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 1.07% | 2.28% | -1.21 | UNH | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 5.40 | 3.12 | +2.28 | STE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 7/9 | +2.00 | STE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | 6.74% | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 62.4 | 59.2 | +3.20 | STE | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.08 | 0.33 | +0.75 | STE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 26.9x | 17.1x | +9.81 | UNH | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $22.63B | $368.83B | -$346.20B | UNH | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | STE REV | UNH REV | STE GROSS % | UNH GROSS % | STE FCF | UNH FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $5.94B | $447.57B | 44.2% | 88.7% | $972.4M | $16.07B |
| FY 2024 | $5.46B | $400.28B | — | 88.3% | $778.0M | $20.70B |
| FY 2023 | $5.14B | $371.62B | — | 89.6% | $742.1M | $25.68B |
| FY 2022 | — | $324.16B | — | 89.6% | — | $23.40B |
| FY 2021 | — | $287.60B | — | 89.2% | — | $19.89B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
STE // BETA 1.08
UNH // BETA 0.33